FEBS Letters | |
Streptozotocin, an inducer of NAD+ decrease, attenuates M‐potassium current inhibition by ATP, bradykinin, angiotensin II, endothelin 1 and acetylcholine in NG108‐15 cells | |
Noda, Mami1  Hoshi, Naoto1  Egorova, Alla1  Higashida, Haruhiro1  | |
[1] Department of Biophysics, Kanazawa University School of Medicine, Takara-machi 13-1, Kanazawa 920, Japan | |
关键词: K+ current; Signal transduction; Second messenger; NAD+; Neuroblastoma × glioma hybrid cell; | |
DOI : 10.1016/0014-5793(95)01516-7 | |
学科分类:生物化学/生物物理 | |
来源: John Wiley & Sons Ltd. | |
【 摘 要 】
The M-potassium current was inhibited by bath application of 100 μM ATP, 10 nM bradykinin, 100 nM angiotensin II and 100 nM endothelin 1 as well as by 10 μM acetylcholine in an ml-muscarinic acetylcholine receptor-transformed NG108-15 cell line. The inhibition of M-current was attenuated in cells pretreated with 5 mM streptozotocin for 5–15 h and restored by simultaneous incubation with 5 mM nicotinamide. The results suggest that signal transduction from these five different receptors to M channels shares a common pathway which is susceptible to a streptozotocin-induced decrease in cellular NAD+ content.
【 授权许可】
Unknown
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201912020302271ZK.pdf | 252KB | download |